How to keep innovation alive in pharma: lessons from The Patient Support Summit

This is a spicy take 🌶️🔥 but it really shouldn't be. "𝘞𝘦 𝘩𝘢𝘷𝘦 𝘵𝘰 𝘬𝘦𝘦𝘱 𝘱𝘶𝘴𝘩𝘪𝘯𝘨 𝘵𝘩𝘦 𝘣𝘰𝘶𝘯𝘥𝘢𝘳𝘺 – 𝘳𝘦𝘴𝘱𝘰𝘯𝘴𝘪𝘣𝘭𝘺. 𝘎𝘰𝘷𝘦𝘳𝘯𝘢𝘯𝘤𝘦 𝘢𝘯𝘥 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘤𝘢𝘯’𝘵 𝘣𝘦 𝘦𝘯𝘦𝘮𝘪𝘦𝘴." It's one of the key points that these pharma leaders hammered on today at The Patient Support Summit . Our industry's "zero-tolerance policy" for data risk is at the heart of what’s holding back patient access. We’ve built strong rules to 𝗽𝗿𝗼𝘁𝗲𝗰𝘁 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮𝗻𝗱 𝗱𝗮𝘁𝗮. And we should maintain strong standards. But we can't do it at the cost of innovation and 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀. So where specifically are we held back? 𝟭/ 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 & 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 There’s enormous untapped value in the data already sitting inside PSPs and specialty networks. Rigid governance stalls innovation through access to data – even when data insights could improve adherence or outcomes today. “𝘛𝘩𝘦 𝘳𝘪𝘤𝘩𝘯𝘦𝘴𝘴 𝘰𝘧 𝘥𝘢𝘵𝘢 𝘪𝘯 𝘰𝘶𝘳 𝘮𝘢𝘳𝘬𝘦𝘵 𝘪𝘴 𝘴𝘦𝘤𝘰𝘯𝘥 𝘵𝘰 𝘯𝘰𝘯𝘦 – 𝘣𝘶𝘵 𝘪𝘵’𝘴 𝘰𝘧𝘵𝘦𝘯 𝘶𝘯𝘥𝘦𝘳-𝘭𝘦𝘷𝘦𝘳𝘢𝘨𝘦𝘥 𝘣𝘦𝘤𝘢𝘶𝘴𝘦 𝘰𝘧 𝘨𝘭𝘰𝘣𝘢𝘭 𝘤𝘰𝘯𝘴𝘵𝘳𝘢𝘪𝘯𝘵𝘴. 𝘉𝘦 𝘵𝘩𝘦 𝘢𝘥𝘷𝘰𝘤𝘢𝘵𝘦 𝘧𝘰𝘳 𝘺𝘰𝘶𝘳 𝘭𝘰𝘤𝘢𝘭 𝘮𝘢𝘳𝘬𝘦𝘵. 𝘚𝘩𝘰𝘸 𝘵𝘩𝘦 𝘷𝘢𝘭𝘶𝘦 𝘰𝘧 𝘵𝘩𝘢𝘵 𝘥𝘢𝘵𝘢 𝘵𝘰 𝘺𝘰𝘶𝘳 𝘮𝘦𝘥𝘪𝘤𝘢𝘭, 𝘢𝘤𝘤𝘦𝘴𝘴, 𝘢𝘯𝘥 𝘱𝘰𝘭𝘪𝘤𝘺 𝘵𝘦𝘢𝘮𝘴. 𝟮/ 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗲𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 Manufacturers want to personalize outreach, automate touchpoints, or use AI to predict drop-off risk. “𝘈𝘯𝘺 𝘥𝘪𝘨𝘪𝘵𝘢𝘭 𝘤𝘢𝘱𝘢𝘣𝘪𝘭𝘪𝘵𝘺 𝘵𝘩𝘢𝘵 𝘳𝘦𝘮𝘰𝘷𝘦𝘴 𝘥𝘪𝘴𝘤𝘰𝘯𝘯𝘦𝘤𝘵𝘴 𝘪𝘯 𝘵𝘩𝘦 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘫𝘰𝘶𝘳𝘯𝘦𝘺 𝘪𝘴 𝘸𝘩𝘢𝘵’𝘴 𝘮𝘢𝘬𝘪𝘯𝘨 𝘢 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘤𝘦. 𝘌𝘷𝘦𝘯 𝘴𝘮𝘢𝘭𝘭 𝘴𝘵𝘦𝘱𝘴 – 𝘭𝘪𝘬𝘦 𝘣𝘳𝘪𝘯𝘨𝘪𝘯𝘨 𝘴𝘱𝘦𝘤𝘪𝘢𝘭𝘵𝘺 𝘱𝘩𝘢𝘳𝘮𝘢𝘤𝘺 𝘢𝘯𝘥 𝘗𝘚𝘗 𝘵𝘦𝘢𝘮𝘴 𝘰𝘯𝘵𝘰 𝘰𝘯𝘦 𝘱𝘭𝘢𝘵𝘧𝘰𝘳𝘮 – 𝘤𝘢𝘯 𝘦𝘭𝘪𝘮𝘪𝘯𝘢𝘵𝘦 𝘮𝘶𝘭𝘵𝘪𝘱𝘭𝘦 𝘵𝘰𝘶𝘤𝘩𝘱𝘰𝘪𝘯𝘵𝘴 𝘧𝘰𝘳 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴.” The next wave of progress will come from people who know how to move carefully But carefully ≠ slowly. The challenge now is building systems that protect patients and make progress possible. Thanks for an insightful discussion! Sameen Rehman(McKesson), Kiran Patel, MBA ( AstraZeneca), Matt Simioni ( Shoppers Drug Mart Specialty Health Network), Jessica Lovett(Cencora) 🫡

  • No alternative text description for this image

Is this a dogwhistle for abolishing HIPAA?

  • No alternative text description for this image

To view or add a comment, sign in

Explore content categories